Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. news
  3. drug design and development
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Events
Downloads
Videos

Refine by
Date

  • This month
  • This Year
  • Older

Drug Design And Development Articles & Analysis

681 news found

Advanced Instruments’ acquisition of Nova Biomedical completed

Advanced Instruments’ acquisition of Nova Biomedical completed

Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in financing. The remainder of the ...

ByArtel, Inc. by Advanced Instruments


Biopharma PEG Achieves FDA DMF Approval for HZ-PEG-HZ

Biopharma PEG Achieves FDA DMF Approval for HZ-PEG-HZ

Watertown, MA - June 29, 2025 - Biopharma PEG, a leading innovator in high-quality polyethylene glycol (PEG) derivatives, today announced it has successfully obtained Drug Master File (DMF) approval from the U.S. Food and Drug Administration (FDA) for its self-developed HZ-PEG-HZ (1K) product. The assigned DMF number is 041864. This significant achievement underscores Biopharma PEG's robust ...

ByBiopharma PEG Scientific Inc


Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7)

Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7)

Versatile compound shows promise in drug synthesis, metal chelation, antioxidant activity, and moreChangsha, China – May 22, 2025– Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers and pharmaceutical developers worldwide. This ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the expansion and enhancement of its comprehensive Drug Discovery Services to help scientists advance antiviral therapeutic development, including target selection and validation, hit selection and optimization, and preclinical development. These new services will support ...

ByCreative Diagnostics


Huateng Pharma to Showcase Extensive PEG Derivatives and CDMO Capabilities at CPHI Japan 2025

Huateng Pharma to Showcase Extensive PEG Derivatives and CDMO Capabilities at CPHI Japan 2025

Changsha, China – 18 March 2025 – Hunan Huateng Pharmaceutical Co., Ltd., a global leader in PEG derivatives and CDMO services for APIs and intermediates, is pleased to announce its participation in CPHI Japan 2025. The company will exhibit its comprehensive product lines and cutting-edge capabilities at Booth No. 4X-06, located at Tokyo Big Sight, Tokyo, Japan, from April 9th to ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Creative Proteomics Unveils Cutting-Edge N-terminal Edman Degradation Service for Advanced Protein Sequencing

Creative Proteomics Unveils Cutting-Edge N-terminal Edman Degradation Service for Advanced Protein Sequencing

Creative Proteomics, a global leader in proteomics and bioanalytical services, has launched its state-of-the-art N-terminal Edman Degradation service, offering researchers a precise and reliable solution for protein sequence analysis. This service leverages the classic Edman Degradation method, refined with modern technology, to deliver unparalleled accuracy in determining the N-terminal ...

ByCreative Proteomics


Creative Proteomics Introduces Central Carbon Metabolism Analysis Service to Accelerate Metabolic Research   

Creative Proteomics Introduces Central Carbon Metabolism Analysis Service to Accelerate Metabolic Research  

Creative Proteomics also offers customizable experimental designs to meet specific research objectives, further enhancing its versatility and applicability across various scientific fields. ...

ByCreative Proteomics


Advanced Instruments to acquire and merge with Nova Biomedical

Advanced Instruments to acquire and merge with Nova Biomedical

Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology ...

ByAdvanced Instruments


Proregulations' Comprehensive EU MAA Solutions

Proregulations' Comprehensive EU MAA Solutions

Obtaining the Marketing Authorisation Application (MAA) is a key step in the commercialization of drugs in the EU, and also an important help to promote the global market expansion of pharmaceutical companies. The MAA is complicated by the need to consider both European economic integration and the independence of individual member states. As a specialist in regulatory matters, Proregulations has ...

ByProregulations


Breakthroughs in Neurology and Oncology: Advancing Patient Well-Being with Innovative Therapies

Breakthroughs in Neurology and Oncology: Advancing Patient Well-Being with Innovative Therapies

Medical science is witnessing remarkable advancements in neurology and oncology, with cutting-edge technologies shaping the future of patient care. Transcranial techniques are improving neurological diagnostics, while tumor tissue-based technology is revolutionizing cancer treatment, particularly in prostate cancer screening. In dermatology, new methods for treating benign epidermal lesions are ...

ByContent Management Test Company. Sugar


Ace Therapeutics Launches In Vivo Models of Diabetes Mellitus to Enhance Diabetes Research Outcomes

Ace Therapeutics Launches In Vivo Models of Diabetes Mellitus to Enhance Diabetes Research Outcomes

As the prevalence of diabetes continues to rise, there is an urgent need for advanced research models that can accurately simulate the disease and facilitate the development of effective interventions. Ace Therapeutics’ in vivo models such as diabetes spontaneous models are made to mimic the pathophysiological characteristics of Type 1 and Type 2 diabetes mellitus, ...

ByAce Therapeutics


Protheragen-ING Provides Comprehensive Microneedle Technology Solutions to Achieve Enhanced Drug Delivery Systems   

Protheragen-ING Provides Comprehensive Microneedle Technology Solutions to Achieve Enhanced Drug Delivery Systems  

Utilizing micron-sized needles to administer drugs directly into the skin, the microneedle technology has become a revolutionary tech in the delivery of drugs. ...

ByProtheragen-ING


Biopharma PEG Announces FDA DMF Registration for mPEG-pALD (20K)

Biopharma PEG Announces FDA DMF Registration for mPEG-pALD (20K)

Biopharma PEG, a leading manufacturer of high-quality polyethylene glycol (PEG) derivatives, today announced that its mPEG-pAld (20K) product has successfully achieved DMF (Drug Master File) registration with the U.S. Food and Drug Administration (FDA) under DMF number 040600. “We are thrilled to receive FDA DMF registration for our mPEG-pAld (20K) product,” said Sonia Lee, Marketing ...

ByBiopharma PEG Scientific Inc


Huateng Pharma's mPEG-pALD Receives FDA DMF Filing Approval

Huateng Pharma's mPEG-pALD Receives FDA DMF Filing Approval

Changsha, China – Hunan Huateng Pharmaceutical Co., Ltd. (Huateng Pharma), a global leader in the development and production of high-quality PEG derivatives, is pleased to announce that its mPEG-pALD (20K) has successfully completed its Drug Master File (DMF) filing with the U.S. Food and Drug Administration (FDA), under DMF No. 040600. This achievement highlights Huateng Pharma’s ...

ByHunan Huateng Pharmaceutical Co. Ltd.


CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience

CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, recently unveiled its significantly enhanced online ordering system. This latest update on the website aims to streamline the ordering process for customers, demonstrating CD Bioparticles' commitment that prioritize customer experience, while also creating greater workflow control, making it more ...

ByCD Bioparticles


Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...

ByProtheragen


Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs

Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs

Alfa Chemistry is one of the leading chemical manufacturers and suppliers who has been able to maintain its leadership position in the pharmaceutical sector by offering a broad product portfolio that caters to all aspects of the drug creation process. Always innovative and outstanding, Alfa Chemistry now has an extensive range of products within the pharmaceutical field, including PROTAC building ...

ByAlfa Chemistry


Protheragen-ING Releases Hundreds of APIs: Anti-Tumor APIs, Hypoglycemic APIs, Antipsychotic APIs, Bronchiectasis APIs, Antihypertensive APIs

Protheragen-ING Releases Hundreds of APIs: Anti-Tumor APIs, Hypoglycemic APIs, Antipsychotic APIs, Bronchiectasis APIs, Antihypertensive APIs

This year Protheragen-ING has extended its portfolio of Active Pharmaceutical Ingredients (APIs) to include several hundred new varieties, catering to a broad spectrum of therapeutic needs such as anti-tumor, hypoglycemic, antipsychotic, bronchiectasis, and antihypertensive treatments. Such growth represents Protheragen-ING’s commitment to support researchers worldwide in their quest of ...

ByProtheragen-ING


CD Formulation Reveals Specialty in Oral Thin Film Manufacturing Technologies

CD Formulation Reveals Specialty in Oral Thin Film Manufacturing Technologies

CD Formulation’s commitment to innovation is evident in their comprehensive suite of services, meticulously designed to meet the unique needs of researchers focusing on drug development and delivery. ...

ByCD Formulation


Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs

Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs

Watertown, MA — November 25, 2024—In the spirit of Thanksgiving, Biopharma PEG Scientific Inc. would like to express its sincere gratitude to our esteemed customers and partners for their trust and support. It is a privilege to collaborate with you, and we look forward to further strengthening our partnership in the future.As a gesture of our appreciation, we are pleased to announce a 30% ...

ByBiopharma PEG Scientific Inc

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT